Expression and Clinical Significance of Survivin in Transitional Cell Carcinoma of Bladder

JIN Bai-ye,LUO Jin-dan,FAN Jun,PAN Hao,XIA Dan,GAO Hai-nu,CAI Song-liang

DOI: https://doi.org/10.3760/cma.j.issn.1000-6702.2009.09.009

2009-01-01

Abstract:cuses tumors. Survivin seems to be a promising marker for analyzing clinical stages and predicting the prognosis of TCC.

What problem does this paper attempt to address?

Expression of Survivin and Its Correlation with Expression of Bcl-2 and P53 in Colorectal Adenocarcinoma

SHEN Hua,JI Feng

DOI: https://doi.org/10.13241/j.cnki.pmb.2007.01.015

2007-01-01

Abstract:Objective:To study the expression of apoptosis inhibitor protein of Survivin in colorectal adenocarcinoma (CAC)and its correlation with clinicalpathologic parameters and prognosis and to examine the relationship between the Survivin expression and the expression of Bcl-2 and P53 in colorectal adenocarcinoma.Methods:115 cases of colorectal adenocarcinoma, by immnohistochemical staining,were examined survivin,Bcl-2,and P53.The cases were followed up for 5 years.Results: Survivin was detected in 74 of 115 cases(64.3%).No expression of survivin was observed in normal tissues.There was no correlation between Survivin immnoactivity and clinicalpathologic parameters(P＞0.05).Survivin expression was significantly higher in Bcl-2 positive patients than in Bcl-2 negative cases(88.9% versus 42.6%,p＜0.001),but was not associated with P53(P＞0.05). The 5-year survival rate for the padents with survivin positive was siginificantly lower than that for the patients with survivin negative(p=0.001).Conclusions:Examining surviving in CAC tissue is of significance for tumor patients' prognosis and targeted therapy based on antiapoptosis mechanism.
Expression of Survivin Mrna in Transitional Cell Carcinoma of Bladder and Its Clinical Significance

温端改,曾剑,侯建全,何军

DOI: https://doi.org/10.3969/j.issn.0253-3685.2006.09.002

2006-01-01

Abstract:Objective To investigate the expression of survivin and its clinical significance in human transitional cell bladder carcinoma. Methods Immunohisto-chemistry method was used to detect survivin expression in 75 cases of bladder transitional cell carcinoma The relationship between survivin expression and the clinicopathologic parameters and prognosis was retrospectively analyzed. Result Survivin expression was not detected in healthy bladder mucosa.Survivin expression was positive in 35 of 75(46.7%).The survivin expression positive rate in grade Ⅰ、Ⅱ and Ⅲ tumors was 26.9(7/20),48.5%(16/33)、75.0%(12/16) and in stage Tis～T 1 and T 2～T 4 tumors 34.2%(14/41) and 61.8% (21/34).The survivin expression positive rates were significantly higher in poorly differentiated and invasive bladder cancer.Expression of survivin was correlated well with histological grade、clinical stage and prognosis. Conclusions There was an important role of survivin expression in the development and for the progression of bladder cancer.Survivin expression could be used as a tumor marker for bladder cancer.
Clinicopathological Significance of Survivin Mrna Expression in HCC

潘金飞,彭淑牖,梁中骁,赫军,罗建强,黄顺荣,刘颖斌

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2005.03.012

2005-01-01

Abstract:Objective To study the correlation of mRNA of survivin, an apoptosis inhibitor, to the clinicopathology of HCC and assess the value of survivin expression in invasion and progression of the tumor. Methods RT-PCR was used to detect the expression of survivin mRNA in samples of HCC tissue from 31 patients. The clinicopathological data of these 31 patients were analyzed. Meanwhile, the relationship between the clinicopathological data and expression of survivin mRNA was determined. Results Positive survivin mRNA expression was found in 22 out of the 31 (71%) patients and the neighboring non-tumor and cirrhotic tissues were completely negative for survivin mRNA expression. The expression of survivin mRNA in HCC was not correlated with gender, age, HBsAg, cirrhosis, tumor size, tumor encapsulation and tumor number (P0.5) but significantly correlated to venous invasion, histological differentiation and TNM stage (P0.05). Venous invasion was found in 9 of the 22 (40.91%) patients with positive expression of survivin mRNA (positive group) and none of the 9 patients with negative expression (negative group). There was significant difference between the 2 groups. The number of patients with grades Ⅰ and Ⅱ HCC and that with grade Ⅲ and IV HCC was 7 and 15 in the positive group but 7 and 2 in the negative group, respectively (P0.05). Furthermore, the number of patients with TNM stage Ⅰ and Ⅱ HCC and that with stage Ⅲ and IV HCC was 7 and 15 in the positive group but 7 and 2 in the negative group, respectively (P0.05). Conclusions The expression of survivin mRNA is significantly correlated to venous invasion, histological differentiation and TNM of HCC. Its high expression is of potential value in judging invasion and progression of HCC.
A Study on the Expression of Survivin Gene in Human Gastric Cancer

Qing BI,Feng JI,Kai-ming WANG

DOI: https://doi.org/10.3969/j.issn.1007-0931.2005.06.004

2005-01-01

Abstract:Objective To study the implication of a novel gene survivin,an inhibitor of apoptosis.Methods The expression of survivin mRNA was quantitatively determined by RT-PCR and survivin protein was examined immunohistochemically in 46 gastric cancer tissues and corresponding normal gastric tissues.Results Suvivin mRNA was determined in 32 6% gastric cancer while in 10 87% normal tissues.Suvivin protein expressed in 78% gastric cancer while in 30% normal tissues.There were significant differences (P0 005,P0 05) between gastric cancer and normal tissues.The expression of suvivin mRNA and protein was independent of sex,diameter of tumors,the position of tumor occurrence,gross type,tumor depth,the level of differentiation,vein invasion,lymph nodes metastasis,distant metastasis and TMN staging.Conclusions Suvivin gene may play a role in inhibiting apoptosis in gastric cancer and may function importantly in tumor production but not development.
Expression and Clinical Value of Survivin in Bladder Transitional Cell Carcinoma

孙友文,宣强,肖俊,周林玉,诸禹平

DOI: https://doi.org/10.3969/j.issn.1001-5930.2012.04.009

2012-01-01

Abstract:Objective To study the expression of Survivin in bladder transitional cell carcinoma(BTCC) and the relationship between its expression and the clinicopathological characteristics of BTCCs.Methods 68 cases of paraffin-embeded specimens of BTCC was taken as the experimental group and ten cases of non-tumor patients with normal bladder mucosa as a control group.Using immunohistochemical SP method to detect the expression of Survivin in all specimens,and the results were statistically analyzed.Results The positive rate of Survivin were 72.1% in the BTCC group and 0% in the normal group,respectively(P0.05).The positive rate of Survivin in pathological grade Ⅰ,Ⅱ and Ⅲ were respectively 45.8%,83.3% and 92.9%.There was statistically significant difference between gradeⅠand gradeⅡ,gradeⅢ(P0.05).That of Survivin in superficial,invasive;primary,recurrence;lymph node postive,negetive were 57.9%,90.0%;64.7%,94.1%;57.5%,92.9%;respectively(P0.05).Conclusion The abnormal high expression of Survivin may play an important role in occurrence and progress of BTCC.Detection of Survivin in BTCC is helpful in evaluating the occurrence,progress,metastasis,relapase of BTCC and the prognosis of the patients.Survivin also can provide a new appropriate target for gene therapy to BTCC.
The Correlation and Expression of Survivin and PCNA in Bladder Transitional Carcinoma

赵瑞宁,陈福宝,师宏斌,余洋,吴海峰,卢冠军

DOI: https://doi.org/10.3969/j.issn.1001-5949.2008.02.005

2008-01-01

Abstract:Objective To investigate the expression and clinical significance of Survivin and PCNA in bladder transitional carcinoma and their relativity.Methods The immunohistochemistry(SP method) was used to determine the expression of Survivin,PCNA in 60 cases with BTCC and 10 normal cases with bladder tissues.Results The positive expression rates of Survivin and PCNA in BTCC were significantly higher than those in normal bladder tissue(P0.01).The positive expression rates of Survivin and PCNA increased significantly with increasing pathological grade and clinical stage(P0.05 or P0.01).There was a positive correlation between the expression rates of Survivin and PCNA(P0.01).Conclusion The positive expression rates of Survivin and PCNA are closely associated with tumorigenesis,progress and prognosis of BTCC.
Expressions of survivin and the splice variants survivin-2B and survivin-ΔEx3 in bladder cancer and their clinical significance

Xue-Feng He,Duan-Gai Wen,Jian-Quan Hou,Jun He,Jian-Nong Cen

DOI: https://doi.org/10.5732/cjc.008.10650

2009-01-01

Abstract:Background and Objective: Studies on survivin over the past 5 years have shown that survivin participates in the genesis of several human cancers, including bladder cancer. Recent studies have indicated that survivin splice variants appeared to have unique subcellular localizations and functions as well. This study was to explore the roles of survivin and Its two splice variants survivln-2B and survivin-ΔEx3 in transitional cell carcinoma of bladder (BTCC). Methods: The relative amount of survivin, survivin-2B, and survivin-ΔEx3 mRNA of fresh carcinoma tissues from 60 patients with BTCC and 12 non-cancerous bladder tissues were detected by real-time quantitative reverse transcription polymerase chain reaction (RT-PCR), and the relationships of their expression levels In different pathologic grades to clinical stages of bladder cancer were analyzed. The time of follow-up was 4-24 months. Results: Survivin, survlvin-2B, and survivln-ΔEx3 mRNA were detected in all BTCC tissues, and their relative expressions were 0.333±0.163, 0.056±0.017, and 0.124±0.096, respectively. In the control group,three and four samples expressed survivin and survivin-ΔEx3 mRNA respectively, and all samples expressed survivin-2B mRNA. The expressions of survivin and survivin-ΔEx3 mRNA were positively correlated with the pathologic grades and clinical stages(0<r' s<1, P<0.05), however, survivin-2B mRNA was negativly correlated with those (-1 <r' s<0, P<0.05). Conclusions: Detecting the expression levels of survivin and its two splice variants survivin-2B and survivin-ΔEx3 mRNA in BTCC by real-time PCR could have potential values to evaluate tumor progression and recurrence rate.
Expression of survivin and bcl-2 and their correlation in transitional cell carcinoma of the bladder

Cao Zhengguo,Zhu Yuping,Zhou Siwei,Liu Jihong,Qi Lin,Wu Kui,Su Hong,Xiao Jun

DOI: https://doi.org/10.3969/j.issn.1009-8291.2006.05.006

2006-01-01

Abstract:Objective To study the expression of survivin mRNA and bcl-2 protein, their correlation and the effect on tumor cell apoptosis in transitional cell carcinoma of the bladder (BTCC), and to investigate the role of survivin in the BTCC. Methods RT-PCR and immunohistochemical techniques were respectively used to detect the expression of survivin mRNA and bcl-2 protein in 45 tissues of BTCC. The apoptosis index (AI) was detected by TUNEL method. Results The expression rate of survivin mRNA and bcl-2 protein in BTCC tissues were respectively 71.11% and 51.11%. The high expression of survivin had significant correlation with metastasis of BTCC and some association with the degree of differentiation. However, no correlation was found between the expression and patient age, sexuality, or the clinical staging, diameter, and genesis of tumor tissues. And no correlation between the expression of bcl-2 and the clinical pathological characteristics in BTCC was observed. The AI in the positive expression of survivin and bcl-2 were respectively (4.23±0.68)% and (4.29± 0.67 )%, which were significantly lower than those in the negative expression. There was a significant correlation between the expression of survivin and bcl-2 (χ~ 2 =9.338, P<0.05). Conclusion The high expression of survivin in BTCC tissues suggests that it participates in the mechanism of genesis and development of BTCC and can be used as an important prognostic index. Survivin with bcl-2 may play a synergic role in the regulation of cell apoptosis in BTCC.
Overexpression of survivin in ovarian transitional cell carcinoma

GU Junjie,YAO Xuequan,HAN Suping

DOI: https://doi.org/10.3969/j.issn.0253-3685.2007.02.011

2007-01-01

Abstract:Objective To study the expression of a novel apoptotic inhibitor, survivin, in ovarian transitional cell carcinoma(TCC). Methods Survivin protein expression was detected in 52 ovarian TCCs and 25 normal ovarian tissues by immunohistochemistry.Results Survivin protein expression was detected in 80.6 % (29/36) ovarian TCCs, but no expression in normal ovarian tissues(P<0.01). Overexpression of survivinprotein was significantly related to the poor prognosis of ovarian TCC patients (P<0.05).Conclusion Survivin plays an important role in the pathogenesis and development of ovarian TCCs.
Expression of Apoptosis Inhibitor Gene Survivin in Bladder Carcinoma and Its Clinical Implication

宋涛,李鸣,石怀银,洪宝发,那彦群

DOI: https://doi.org/10.3760/j:issn:1000-6702.2004.12.017

2004-01-01

Abstract:Objective To study the expression of survivin, an apoptosis inhibitor gene,in bladder carcinoma,and to investigate its clinical and pathological implications. Methods We detected the expression of survivin in 60 cases (48 men and 12 women) of bladder carcinoma and 10 cases of non-tumor bladder tissues (controls) by immunohistochemistry (SP) method.The mean age of the 60 cases at diagnosis was 59 years.The pathological grading showed Grade Ⅰ in 16 cases,Grade Ⅱ in 24 and Grade Ⅲ in 20.The clinical staging showed T 1 in 13 cases,T 2 in 15,T 3 in 21 and T 4 in 11.Of the 60 cases,21 developed relapse. Results The overall positive rate of survivin in 60 cases of bladder carcinoma was 60.0% (n=36).No survivin was found in 10 cases of non-tumor bladder tissues.The positive rate of survivin in Grade Ⅰ cases of bladder carcinoma was 37.5%(6/16),in Grade Ⅱ and Ⅲ cases of bladder carcinoma was 66.7%(16/24) and 70.0%(14/20);the difference of positive rates between Grade Ⅰ and Grade Ⅱ,Grade Ⅲ cases was significant (P0.01).The positive rates of survivin in T 1,T 2,T 3 and T 4 cases of bladder carcinoma were 53.8%(7/13),60.0%(9/15),61.9%(13/21) and 63.6%(7/11),respectively,which showed a trend of increasing,but there was no statistically significant difference among them (P0.05).The positive rate of survivin in cases of relapse was 80.9% (17/21). Conclusions Survivin may play an essential role in bladder carcinogenesis and serve as a marker for prognosis of bladder cancer.
Expression of Survivin in Bladder Transitional Cell Carcinoma and Its Relationship with Expression of Fas/FasL

WU Changli,ZHAO Zuohui,ZHANG Shumin,ZHANG Wenlan,CHANG Jiwu,SUN Guang,HAN Ruifa

2006-01-01

Abstract:Objective: To study the expression of Survivin in bladder transitional cell carcinoma (BTCC) and the relationship with pathological stage of BTCC and Fas/FasL system. Methods: Immunohistochemistry was used to detect the expression of Survivin, Fas and Fasl in BTCC (n = 64), bladder benign lesions (n = 15) and normal bladder mucosa (n = 12). Results: The positive expression of survivin in BTCC(93.8%) was higher than bladder benign lesions(66.7%) and normal bladder mucosa had no expression,the difference was statistical significance (P < 0.01). The expression level of survivin was strongly relatated with pathological grade. The Fas expression rate among BTCC, bladder benign lesions and normal bladder mucosa was 50%, 80% and 100% respectively.Correspondingly,the FasL expression level among BTCC, bladder benign lesions and normal bladder mucosa was 90.6%,60% and 16.7%.The expression of Survivin in the BTCC was up regulated and had a tight relationship with the expression of Fas/FasL. Conclusion: The study suggest that survivin is relatated with the malignancy of BTCC and cooperating with Fas/FasL to promote the initiation and progression of BTCC.
Expression of Inhibitor of Apoptosis Protein Survivin in Clear Cell Renal Cell Carcinoma and It's Clinical Significance

李旭东,曾津,陈玉乐,薛玉泉,吴开杰,杨增雷,张岗,王新阳

DOI: https://doi.org/10.3969/j.issn.1009-8291.2010.02.003

2010-01-01

Abstract:Objective To assess the expression of survivin,a member of the inhibitor of apoptosis protein family,in clear cell renal cell carcinoma(ccRCC)and to determine its clinical significance.Methods Immunohistochemical staining for survivin was performed using paraffin-embedded tissues from 48 cases of ccRCC and 20 cases of normal kidney tissues.We also assessed the expression of survivin in 10 cases of ccRCC by Western blot.Results Of the 48 ccRCC specimens,43(89.58%)showed positive staining of survivin immunohistochemically.In contrast,no expression of survivin was detected in nomal kidney tissues.A significant increase in survivin expression was associated with increased tumor stage,increased tumor grade and distant metastasis(P 0.05).However,there was no significant correlation between the expression of survivin and patient age,sex,tumor size and cancer embolus in inferior vena cava.Western blot analysis in 10 cases of ccRCC also demonstrated the high expression of survivin.Conclusion Survivin-mediated inhibition of apoptosis is associated with progression of renal cell carcinoma.This may be relevant for prognosis and alternative therapeutic approaches of ccRCC.
The Expression and Clinical Significance of Survivin in Renal Cell Carcinoma

Qing Songlin,Liu Ting,Hu Wei,Liu Bolong,Tang Zheng,Zhao Lei

DOI: https://doi.org/10.3760/cma.j.issn.1673-4416.2019.03.028

IF: 2.2662

2019-01-01

International Urology and Nephrology

Abstract:Objective To investigate the effect and significance of Survivin oncogenesis and progression on renal cell carcinoma,and the relationship between Survivin expression and biology behavior(clinical stages,pathological grades and lymphatic metastases)of renal cell carcinoma,providing evidence for diagnosis,therapy and prognosis of renal cell carcinoma.Methods Immunohistochemical analysis was performed to detect the Survivin protein,then carrying out relative analyses between survivin protein expression and clinical stage,pathological grade and lymphatic metastases of renal cell carcinoma.All statistical analyses were carried out with SPSS 21.0 software.The probability of less than 5 ％ was assumed to be statistically significant (P ＜ 0.05).Results ①The positive rate of Survivin protein expression on the renal cell carcinoma was 73.1％ (19/26),and the positive expression of Survivin wasnt found in the normal renal tissues(0/16).Survivin expressions in renal cell carcinoma were significantly higher than those in normal renal tissues,there was significant difference (P ＜ 0.05).②In stage Ⅰ-Ⅱ,the positive rate of Survivin protein was 45.5 ％ (5/11).In stage Ⅲ-Ⅳ,the positive rate of Survivin protein was 93.3 ％ (14/15).There was significant difference between the two groups (P ＜ 0.05).There was significant difference between the two groups (P ＜ 0.05).③In the poorly differentiated group and the differentiation group,the positive rate of Survivin protein expression was 92.3％ (12/13).In the well-differentiated group,the positive rate of Survivin protein expression was 53.8％ (7/13).There was significant difference between the two groups (P ＜ 0.05).There was significant difference between the two groups (P ＜ 0.05).④The positive rate of Survivin protein expression was 93.3％ (14/15) in patients with lymph node metastasis and 45.5％ (5/11) in those without.There was significant association between expression of Survivin protein and metastasis (P ＜0.05).⑤There was no association between the expression of Survivin and ages and sexes of patients.Conclusions ①The expressions of Survivin are significantly higher in renal cell carcinoma than those in normal renal tissue,while no expression of Survivin is detected in the normal kidney tissue.②The expressions of Survivin in renal cell carcinoma are positively related to the clinical stages,pathological grades and lymphatic metastases.The expressions of Survivin in Ⅲ and Ⅳ period group are higher than those in Ⅰ and Ⅱ period group,and the expressions in the poorly differentiated group and the differentiation group are higher than in the well-differentiated group.In addition,the expression in the lymph node metastasis group is also higher than those in the other group.③Survivin is expected to become an important biological indicator to evaluate the metastasis and prognosis of renal cell carcinoma,and may be a novel therapeutic target of renal cell carcinoma.
Survivin Mrna Expression In Urine As A Biomarker For Patients With Transitional Cell Carcinoma Of Bladder

Hou Jian-Quan,He Jun,Wen Duan-Gai,Chen Zi-Xing,Zeng Jian

DOI: https://doi.org/10.1097/00029330-200607010-00012

IF: 6.133

2006-01-01

Chinese Medical Journal

Abstract:Transitional cell carcinoma （TCC） of bladder is the most common malignant tumor in uropoiesis system. Up to date, there is still lack of an ideal marker for the diagnosis of TCC except CT and MRI imaging and cystoscopy. Cystoscopy is an invasive examination, which increases the possibility of urinary tract infection. Urine cytology has low sensitivity （21% -40%） in diagnosis of bladder cancer, especially for those with medium or high differentiation. The specificity is often affected by factors such as specimen collection, urinary tract infection, etc. Detecting the expression of survivin mRNA in urine by real time-PCR is simple in specimen collection and is sensitive and relatively specific, which provides a simple and noninvasive diagnostic method for TCC. Moreover it allows comparing the gene expression levels at different stages and grades of TCC, which can help define malignancy degree of TCC.
The Expression and Clinical Significance of Survivin in Gallbladder Carcinoma

NIU Jian,LU Yi,QIAN Hai-xing

DOI: https://doi.org/10.3969/j.issn.1673-0399.2006.02.033

2006-01-01

Abstract:Objective To investigate the expression of Survivin in gallbladder carcinoma and its relation to development of the carcinoma.Methods The expression of Survivin in gallbladder carcinoma was detected by S-P immunohistochemical staining,20 cases of chronic cholecystitis were collected as the controls.Results ①The positivity rate of Survivin in gallbladder carcinoma increased significantly.②In metastasis or low differentiation there was higher expression of Survivin.③There was significant difference in survival time between patients with Survivin(+)and Survivin(-).Conclusions The detection of Survivin may be useful in assessing the development of the cancer,judging prognosis and eventually render a possible target for novel therapeutic strategies.
[Expression and Significance of Survivin in Colon Cancer].

Zhi-Min Jiang,He-Rui Yao,Jun Zhan,De-Rong Xie,Hai-Gang Li

DOI: https://doi.org/10.3969/j.issn.1000-467x.2004.z1.012

2004-01-01

Abstract:BACKGROUND & OBJECTIVE Survivin is a newly identified apoptosis inhibitor. Studies indicated that Survivin over-expressed in malignant tumors. This study was designed to evaluate the expression of Survivin in colon cancer,and the correlation of its expression to clinical characteristics and prognosis of patients with colon cancer. METHODS Expression of Survivin protein was investigated by immunohistochemistry in 12 cases of normal colon tissues,and 79 cases of colon cancer tissues without the history of radiotherapy or chemotherapy. RESULTS Expression of Survivin was detected in 78.5%(62/79) of colon cancer tissues,higher than that in tumor nests adjacent tissues, which was 32.9% (26/79). In contrast, normal colon tissues did not express Survivin. There was no relationship between the expression of Survivin and age, sex, blood type, serum CEA level, lymph node metastasis, histological grade, infiltration degree, and Dukes' stage(P >0.05). When 25% was used as the cut-off point between high and low expression of Survivin, 3-year overall survival rate of low expression group (63.56%) was much higher than that of high expression group (39.96%) (P=0.04). Cox proportional hazards model analysis showed that Dukes' stage, and high expression of Survivin were the only 2 prognosis factors influenced the survival times (Wald values were 24.225, and 5.504, respectively, P values were 0.000, and 0.019, respectively). CONCLUSIONS There is a high expression level of Survivin in colon cancer, it may play an important role in tumorgenesis and development of colon cancer. Over-expression of Survivin was related with poor prognosis, it may be a potential prognostic index.
Expressions of Survivin and Its Variants Mrna in Bladder Transitional Cell Carcinoma

燕翔,丁强,张元芳,徐永华,郭宏骞,孙则禹

DOI: https://doi.org/10.3969/j.issn.0253-3685.2007.06.008

2007-01-01

Abstract:Objective To investigate the expressions of survivin and its variants in bladder transitional cell carcinoma and the relationship between the expression and the stage or grade of bladder cancer. Methods Of 30 patients with bladder transitional cell carcinoma,17 cases were at stage of T_a or T_1, 13 cases T_2～T_4. Twenty three cases were in degree of G_1/ G_2 and 7 cases G_3. Eight cases had the matched pairs of non-neoplastic tissue samples. Eight samples of normal bladder mucosa were from non-tumor cases. Total RNA was extracted from bladder cancer tissues according to the TRIzol protocol. cDNA was synthesized from total RNA of each sample,and cDNA was used for PCR. Glyceraldehyde phosphate dehydrogenase(GAPDH) was also amplified as an internal control. The PCR bands were analyzed by BIO-RAD Quantity One 4.5 software. Results In 28 cases of 30 tumor tissue samples, the expressions of survivin and its variants were detected. Survivin was the predominant transcript variant, whereas only low level of survivin-Ex3 and survivin-2B were observed. The differences of expression between the survivin variants were statistically significant(P0.01).In contrast, a significant decrease in the expression of the non-anti-apoptotic survivin-2B variant became evident at advanced stages or grades of bladder cancer(P0.01).Conclusion We have found the variants of survivin in bladder cancer, and demonstrated that the expression of survivin-2B at high stage or grade bladder cancer is down-regulated,indicating that its antiapoptotic function may be lower than other variants.
[Expression of Survivin in Different Stages of Carcinogenesis and Progression of Breast Cancer].

Shu-Qun Zhang,Shui-Yun Qiang,Wen-Bin Yang,Jian-Tao Jiang,Zong-Zheng Ji

DOI: https://doi.org/10.3969/j.issn.1000-467x.2004.06.019

2004-01-01

Abstract:BACKGROUND & OBJECTIVE Survivin is one of the newly identified apoptosis inhibitor; it can block the cell apoptosis by inhibiting the function of the enzyme caspase-3 and caspase-7. Present studies indicate that survivin is overexpressed in malignant tumor. This current study was designed to investigate the effects of survivin in tumorigenesis and progression of breast carcinoma through observing the expression of survivin in the tissue of normal mammary, cystic hyperplasia mammary, atypical hyperplasia mammary and breast carcinoma. METHODS The expression of survivin in the tissue of normal mammary (96 cases), cystic hyperplasia mammary (56 cases), atypical hyperplasia mammary (12 cases), and breast carcinoma (119 cases) were evaluated by SP immunohistochemistry. The relationship between survivin expression and the pathologically biological features of breast cancer was assessed. RESULTS The positive rates of survivin were 4.2%(4/96),5.4% (3/56),42.7% (5/12), and 72.3%(86/119)in the tissue of normal mammary, cystic hyperplasia mammary, atypical hyperplasia mammary, and breast carcinoma, respectively. The positive rates in the last two groups were higher than those in the former two groups (P< 0.005). Survivin was more expressed in the infiltrative nonspecial breast carcinoma (82.0%, 73/89) than in the special and early stage infiltrative breast carcinoma (37.5%,3/8)(P< 0.05). Expression of survivin was correlated with lymph node metastasis although the difference is not significant (P >0.05). CONCLUSION Overexpression of survivin is common in tumorigenesis and progression of breast carcinoma. Altered expression of survivin may contribute to tumorigenesis and progression of breast carcinoma by inhibiting cell apoptosis, its overexpression indicates worse prognosis.
Correlation Between the Expression of Survivin and VEGF in BTCC and the Clinical Significance

常宏,王永康,吴泰璜,穆庆岭,靖昌庆,潘晓华

DOI: https://doi.org/10.3760/j.issn:1001-9030.2004.06.011

2005-01-01

Abstract:Objective: To investigate the expression of survivin and its relatio nship with the clinical feature of bladder transitional cell carcinoma (BTCC) ,a nd the correlation between the expression of survivin and vascular endothelial c ell growth factor (VEGF). Methods: In 42 specimens of BTCC tissues and 20 non-c ancerous adjacent bladder tissues,16 normal bladder tissues the expression of su rvivin and VEGF was detected by using in situ hybridization. Results: Of the 23 (60. 5 %) cases of BTCC expressing survivin in 42 cases of BTCC,22 were positiv e for the expression of VEGF and 1 was negative. Of the 19 cases not expressing survivin ,1 case was positive for VEGF and 18 negative. Survivin was not detecte d in non-cancerous adjacent bladder tissues and normal bladder tissues. The expr ession of survivin in BTCC had a close association with the tumor differentiated level,clinical stages and infiltration of BTCC. There was a close correlation between the expression of survivin and VEGF,proved by the correlation test. Conc lusion: Survivin and VEGF are over-expressed in BTCC tissues. The progression o f BTCC is related to the up-regulation of the expression of survivin and VEGF. T he expression of survivin and VEGF has a close correlation.
Expression of Surviving Mrna in Exfoliate Cells in Urine of the Patients with Transitional Cell Carcinoma of Bladder

曾剑,温端改,何军,侯建全

DOI: https://doi.org/10.3760/j.issn:1001-9030.2005.05.019

2005-01-01

Abstract:Objective To explore the expression of Survivin mRNA in exfoliate cells in urine of the patients with transitional cell carcinoma of bladder (TCC),and its relation with the occurrence,development,differentiation and pathologic grading and clinical staging of TCC.Methods Fresh urine of 30 patients with TCC and 18 healthy volunteers who voided the second urine in morning was collected.The expression of Survivin mRNA in the urine was detected by semiquantitative reverse transcription polymerase chain reaction (RT-PCR).Results The positive rate of the Survivin mRNA expression in the exfoliate cells in urine was 100% in the patient group and 22.2% in the control group respectively.There were significance between them.The gray degree ratios of the Survivin mRNA to the β-actin mRNA varied accordingly to different pathologic grades and clinical stages (grade I: 1.00± 0.18, grade Ⅱ: 1.28± 0.14, grade Ⅲ: 1.70± 0.23, without break through basement membrane: 1.01± 0.17, superficial muscle invasion: 1.26± 0.14, deep muscle invasion: 1.70± 0.23), and there was significant difference between them (P 0.01). Conclusion Detecting Survivin mRNA in the urine can be used in diagnosing TCC,judging the malignancy degree of TCC and the prognosis of TCC.

Expression and Clinical Significance of Survivin in Transitional Cell Carcinoma of Bladder

Expression of Survivin and Its Correlation with Expression of Bcl-2 and P53 in Colorectal Adenocarcinoma

Expression of Survivin Mrna in Transitional Cell Carcinoma of Bladder and Its Clinical Significance

Clinicopathological Significance of Survivin Mrna Expression in HCC

A Study on the Expression of Survivin Gene in Human Gastric Cancer

Expression and Clinical Value of Survivin in Bladder Transitional Cell Carcinoma

The Correlation and Expression of Survivin and PCNA in Bladder Transitional Carcinoma

Expressions of survivin and the splice variants survivin-2B and survivin-ΔEx3 in bladder cancer and their clinical significance

Expression of survivin and bcl-2 and their correlation in transitional cell carcinoma of the bladder

Overexpression of survivin in ovarian transitional cell carcinoma

Expression of Apoptosis Inhibitor Gene Survivin in Bladder Carcinoma and Its Clinical Implication

Expression of Survivin in Bladder Transitional Cell Carcinoma and Its Relationship with Expression of Fas/FasL

Expression of Inhibitor of Apoptosis Protein Survivin in Clear Cell Renal Cell Carcinoma and It's Clinical Significance

The Expression and Clinical Significance of Survivin in Renal Cell Carcinoma

Survivin Mrna Expression In Urine As A Biomarker For Patients With Transitional Cell Carcinoma Of Bladder

The Expression and Clinical Significance of Survivin in Gallbladder Carcinoma

[Expression and Significance of Survivin in Colon Cancer].

Expressions of Survivin and Its Variants Mrna in Bladder Transitional Cell Carcinoma

[Expression of Survivin in Different Stages of Carcinogenesis and Progression of Breast Cancer].

Correlation Between the Expression of Survivin and VEGF in BTCC and the Clinical Significance

Expression of Surviving Mrna in Exfoliate Cells in Urine of the Patients with Transitional Cell Carcinoma of Bladder